The National Institutes of Health recently unveiled a collaborative program that will match researchers with a selection of pharmaceutical industry compounds to help scientists explore new treatments for patients. NIH’s new National Center for Advancing Translational Sciences (NCATS) has partnered initially with Pfizer, AstraZeneca, and Eli Lilly and Company which have agreed to make dozens of their compounds available for this initiative’s pilot phase.
NIH Launches Collaborative Program, Matches Researchers with Compounds to Explore New Treatments
Complete Genomics: Top Innovative Company in Biomedicine
Complete Genomics is one of 10 biomedicine companies included in Technology Review’s 50 Most Innovative Companies (TR50) for 2012 [1].
Q&A: What are Nitrates in Food and Why Should I Worry About Them?
Question: I’ve heard that nitrates in food are dangerous and that I should avoid them. What are nitrates, why are they a problem, and what foods contain them?
AssureRx Health Launches Personalized Medicine Test for ADHD
Mason, Ohio-based AssureRx Health announced this week that it has launched a personalized medicine test for attention deficit hyperactivity disorder (ADHD). The new pharmacogenomic test — GeneSightRx ADHD — analyzes variations in three genes that influence how a patient might metabolize certain medications used to treat ADHD in children and adults.